title: Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiation.
abstract: Ubiquitylation is currently recognized as a major posttranslational modification that regulates diverse cellular processes. Pirh2 is a ubiquitin E3 ligase that regulates the turnover and functionality of several proteins involved in cell proliferation and differentiation, cell cycle checkpoints, and cell death. Here we review the role of Pirh2 as a regulator of the DNA damage response through the ubiquitylation of p53, Chk2, p73, and PolH. By ubiquitylating these proteins, Pirh2 regulates cell cycle checkpoints and cell death in response to DNA double-strand breaks or the formation of bulky DNA lesions. We also discuss how Pirh2 affects cell proliferation and differentiation in unstressed conditions through ubiquitylation and degradation of c-Myc, p63, and p27(kip1). Finally, we link these different functions of Pirh2 to its role as a tumor suppressor in mice and as a prognosis marker in various human cancer subtypes.
authors: Ontario Cancer Institute; University Health Network and Department of Medical Biophysics; University of Toronto; Toronto, Ontario, Canada.
authors: Marie-jo
authors: MJ
authors: Halaby
authors: Razqallah
authors: R
authors: Hakem
authors: Anne
authors: A
authors: Hakem
mesh_terms: D000818:Animals; D002453:Cell Cycle; D002454:Cell Differentiation; D004249:DNA Damage; D006801:Humans; D008954:Models, Biological; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*; D054875:Ubiquitination
chemical_list: D044767:Ubiquitin-Protein Ligases
keywords: Chk2; Pirh2; c-Myc; p27Kip1; p53; p63; p73; polH; ubiquitylation
references: Cancer Res. 2001 Nov 15;61(22):8062-7
references: 11719428
references: Mol Cancer Res. 2011 Dec;9(12):1780-90
references: 21994467
references: Cell Cycle. 2007 Aug 15;6(16):1995-2000
references: 17721076
references: J Biol Chem. 2011 Oct 14;286(41):35388-35395
references: 21852228
references: Cell Cycle. 2010 Feb 15;9(4):720-8
references: 20160513
references: Cell Cycle. 2012 Dec 15;11(24):4545-51
references: 23165243
references: J Biol Chem. 2013 Feb 1;288(5):2907-13
references: 23271742
references: Mol Cell Biol. 2011 Oct;31(19):3997-4006
references: 21791603
references: PLoS Genet. 2011 Nov;7(11):e1002360
references: 22125490
references: Oncogene. 2009 Sep 3;28(35):3157-66
references: 19581926
references: Cell. 2006 Aug 11;126(3):529-42
references: 16901786
references: Exp Cell Res. 2012 Jul 1;318(11):1285-90
references: 22326462
references: Mol Cell Biol. 2006 Sep;26(17):6502-10
references: 16914734
references: J Invest Dermatol. 2013 May;133(5):1178-87
references: 23235527
references: Cancer Cell. 2005 Apr;7(4):363-73
references: 15837625
references: Nat Struct Mol Biol. 2008 Dec;15(12):1334-42
references: 19043414
references: Nature. 2000 Mar 2;404(6773):99-103
references: 10716451
references: Mol Cell Biol. 2008 Oct;28(19):5874-85
references: 18644861
references: Mutat Res. 2004 Oct 4;554(1-2):215-21
references: 15450420
references: EMBO J. 2007 Feb 21;26(4):923-34
references: 17268548
references: Cell Death Differ. 2013 Jun;20(6):812-22
references: 23449389
references: Science. 1998 Dec 4;282(5395):1893-7
references: 9836640
references: Cell Cycle. 2007 Feb 1;6(3):229-32
references: 17297295
references: FEBS Lett. 2012 May 21;586(10):1397-402
references: 22673504
references: Cell Cycle. 2009 Feb 1;8(3):430-7
references: 19176998
references: J Cell Sci. 2000 May;113 ( Pt 10):1661-70
references: 10769197
references: FEBS Lett. 2011 Sep 16;585(18):2803-9
references: 21624367
references: Dev Cell. 2002 May;2(5):607-16
references: 12015968
references: Cell. 2003 Mar 21;112(6):779-91
references: 12654245
references: Cancer Res. 2007 Nov 15;67(22):10789-95
references: 18006823
references: EMBO J. 2005 Feb 23;24(4):836-48
references: 15678106
references: Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a001883
references: 20066118
references: Nat Rev Mol Cell Biol. 2008 Oct;9(10):759-69
references: 18813293
references: J Mol Endocrinol. 2002 Aug;29(1):41-60
references: 12200228
references: Nat Rev Cancer. 2007 Dec;7(12):925-36
references: 18004398
references: Trends Cell Biol. 2008 May;18(5):244-52
references: 18406616
references: J Natl Cancer Inst. 2004 Nov 17;96(22):1718-21
references: 15547185
references: Cell Cycle. 2010 Jun 15;9(12):2342-52
references: 20519948
references: J Biol Chem. 2007 Oct 12;282(41):30311-21
references: 17715138
references: Nat Rev Cancer. 2008 Apr;8(4):253-67
references: 18354415